a b s t r a c t NADPH oxidases are the major sources of reactive oxygen species in cardiovascular, neural, and kidney cells. The NADPH oxidase 5 (NOX5) gene is present in humans but not rodents. Because Nox isoforms in renal proximal tubules (RPTs) are involved in the pathogenesis of hypertension, we tested the hypothesis that NOX5 is differentially expressed in RPT cells from normotensive (NT) and hypertensive subjects (HT). We found that NOX5 mRNA, total NOX5 protein, and apical membrane NOX5 protein were 4.2 70.7-fold, 5.27 0.7-fold, and 2.87 0.5-fold greater in HT than NT. Basal total NADPH oxidase activity was 4.57 0.2-fold and basal NOX5 activity in NOX5 immunoprecipitates was 6.2 70.2-fold greater in HT than NT (P¼ o0.001, n ¼6-14/group). Ionomycin increased total NOX and NOX5 activities in RPT cells from HT (Po 0.01, n ¼4, ANOVA), effects that were abrogated by pre-treatment of the RPT cells with diphenyleneiodonium or superoxide dismutase. Silencing NOX5 using NOX5-siRNA decreased NADPH oxidase activity ( À 45.17 3.2% vs. mock-siRNA, n ¼6-8) in HT. D 1 -like receptor stimulation decreased NADPH oxidase activity to a greater extent in NT ( À 32.5 71.8%) than HT ( À 14.8 71.8). In contrast to the marked increase in expression and activity of NOX5 in HT, NOX1 mRNA and protein were minimally increased in HT, relative to NT; total NOX2 and NOX4 proteins were not different between HT and NT, while the increase in apical RPT cell membrane NOX1, NOX2, and NOX4 proteins in HT, relative to NT, was much less than those observed with NOX5. Thus, we demonstrate, for the first time, that NOX5 is expressed in human RPT cells and to greater extent than the other Nox isoforms in HT than NT. We suggest that the increased expression of NOX5, which may be responsible for the increased oxidative stress in RPT cells in human essential hypertension, is caused, in part, by a defective renal dopaminergic system.
Introduction
The reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidases have been studied extensively in phagocytic and non-phagocytic cells, including those from cardiovascular, neural, pulmonary, and renal tissues [1] [2] [3] . The NADPH oxidase family, which has seven members, is classified into three groups:
was initially reported to be expressed in human testis, spleen, and lymph node [14] . More recently, NOX5 has been reported in human vascular endothelial and smooth muscle cells [9, [15] [16] [17] . Five splice variants of human NOX5, namely NOX5α, NOX5β, NOX5γ, NOX5δ, and short NOX5, have been identified [14, 15] . NOX5 differs from the other NADPH oxidase isoforms in that it contains an N-terminal calmodulin-like domain with four binding sites for Ca 2 þ (EF hands) and does not require p22 phox or other subunits for its activation [1, 3] . NOX5 can be activated by thrombin, platelet-derived growth factor, angiotensin II, endothelin 1, and protein kinase C [15] [16] [17] [18] [19] [20] [21] [22] . NOX5 can also be directly regulated by intracellular Ca 2 þ , the binding of which induces a conformational change, leading to enhanced ROS generation [18] [19] [20] [21] [22] [23] . Dopamine is an important regulator of sodium balance and blood pressure through an independent peripheral dopaminergic system [11, 24, 25] . Knockout of any of the dopamine receptor subtypes (D 1 R, D 2 R, D 3 R, D 4 R, and D 5 R) results in hypertension, the pathogenesis of which is receptor subtype-specific [24] . D 1 -like receptor (comprised of D 1 R and D 5 R) regulation of renal proximal tubule (RPT) sodium transport is defective in genetically hypertensive rats and patients with essential hypertension [11, [24] [25] [26] [27] [28] [29] [30] [31] [32] . More specifically, D 1 R function is impaired in RPT cells from humans with essential hypertension [33] . Both decreased dopamine receptor function and increased ROS production contribute to the pathogenesis of essential hypertension [2, 11, 24, 25] . D 1 -like receptors inhibit oxidative stress in vascular smooth muscle and RPT cells [11, [28] [29] [30] [31] . However, oxidative stress can also cause dysfunction of D 1 R in rat RPT cells [32] and ROS production is increased in RPT cells from spontaneously hypertensive rats (SHRs) [34] . NADPH oxidase activity and protein levels of Nox2 and Nox4 are greater in kidneys and cerebral arteries of SHRs than those from their normotensive controls (Sprague-Dawley and Wistar-Kyoto [WKY]) rats [29] [30] [31] 35] . We now report for the first time that NOX5 is the predominant NADPH oxidase isoform expressed in human RPT cells, the expression of which is greater in RPT cells from hypertensive (HT) than normotensive subjects (NT). We suggest that increased NOX5 expression and activity may contribute to the increased oxidative stress in human essential hypertension.
To read materials and some methods, please see the online supplement.
Methods

Cell sources and cell culture
RPT cells, from histologically normal sections of human kidneys freshly obtained from adult normotensive (NT: NT9, NT16, and NT22) and hypertensive subjects (HT: HT2, HT14, and HT19) who had unilateral nephrectomy due to renal carcinoma or trauma, were grown in culture [33] . These cells have been characterized for D 1 -like receptor expression and function (i.e., response to dopamine and dopamine receptor agonists and antagonists) [33, 36] .
The human RPT cells were maintained in phenol-free Dulbecco's modified Eagle's medium/F12 medium supplemented with 10% fetal bovine serum (FBS), epidermal growth factor (10 ng/ml), ITS TM premix (insulin, transferrin, and selenium), hydrocortisone (36 ng/ml), triiodothyronine (4 pg/ml), and primocin (500 μg/ml) at 37 1C in humidified 5% CO 2 /95% air [31, 33, 36] .
Measurement of NADPH oxidase activity
NADPH oxidase activity was measured in triplicate, using whole cell membranes in the presence of lucigenin (10 μmol/L) and NADPH (100 μmol/L), as described previously [8, 29, 31] . The dynamic tracings of NADPH oxidase-dependent activity were recorded for 180 s (AutoLumat Plus luminometer, LB953, EG&G Berthhold, Germany) and the results expressed as arbitrary light units (ALU), corrected for protein concentration. We also measured ROS production in whole cell homogenates, in the presence of lucigenin (10 μmol/L) and NADPH (100 μmol/L), using a microplate luminometer (MicroWin 2000). NADPH oxidase activity was expressed as relative luminescence units (RLU), corrected for protein concentration. Protein concentrations were determined by a bicinchoninic acid kit. To compare vehicle and drug treatment groups, the percentage of the absolute value of each drug treatment relative to the absolute mean of the vehicle-treated controls was calculated.
In some experiments, calcium-dependent NADPH oxidase activity in RPT cells was measured [9, 18, 19, 23] . Whole RPT cell membranes were prepared as described above and membrane oxidase activity was measured in the absence or presence of CaCl 2 (1.0 mmol/L) [9, 19, 23] . The difference between NADPH oxidase activity in the absence calcium (total NADPH oxidase activity) and NADPH oxidase activity in the presence of Ca 2 þ (NOX5 activity)
represented Ca 2 þ -independent oxidase activity [9] . The NADPH oxidase activities were expressed as RLU/50 μg protein and converted to % change of NT as described previously [8, 29, 31] .
Measurement of NOX5 activity in NOX5-immunoprecipitates
Because there is no specific test for NOX5 activity, we first isolated NOX5 from the other NADPH oxidase isoforms by immunoprecipitation, as described under "Materials and Methods", Supplementary information. The immunoprecipitates (IPs) were washed twice with ice-cold PBS and then finally washed once with assay buffer. NOX5 assay buffer was reconstituted as described [9, 19, 23] . NOX5 activity was measured in duplicate, by incubating the NOX5 immunoprecipitates with assay buffer (200 μl) containing 1 Â PBS buffer, pH 7.4, (mmol/L) 100 KCl, 2 MgCl 2 , and 1 EGTA, 100 mM FAD (Sigma-Aldrich), in the presence of 1.0 mmol/L CaCl 2 and 50 mmol/L lucigenin. The reaction was allowed to proceed for 20 min at 37 1C in a water bath. The supernatants, in duplicate, were immediately transferred into a 96-well microplate and read on a luminometer (MicroWin 2000) at 25 1C following the injection (20 μl) of NADPH (200 μmol/L, final concentration) and monitored for 30 min. Normal rabbit IgG IPs served as negative controls. NOX5 activity was expressed as relative luminescence units (RLU) and converted to % of control values [8, 29, 31] . In some cases RPT cell membrane NADPH oxidase activity was measured using the same protocol.
Measurement of extracellular ROS production
Extracellular ROS production was measured in triplicate by the superoxide dismutase (SOD)-inhibitable reduction of cytochrome c (absorbance at 550 nm). Cells (5 Â 10 6 cells/well) cultured on 12-well plates were incubated in 0. 
Real-time quantitative PCR
Total RNA was extracted from RPT cells with the RNeasy Mini Kit (Qiagen Inc., Valencia, CA) and reverse transcription (RT) was performed using M-MLV reverse transcriptase (Invitrogen). Two micro liters of the RT product was used for real-time PCR (SYBR Green qPCR Supermix UDG Kit, Invitrogen): 50 1C for 2 min and 95 1C for 10 min, followed by 40 cycles at 95 1C for 15 s and 63 1C for 60 s. The human NOX5 primers were 5'-AACTTCTG-GAAGTGGCTGCT-3' (sense, nt #1251-71), and 5'-GAGGAGATGAGT-GACCTTGGA-3' (antisense, nt # 1376-86). Human GAPDH primers were 5'-GTCGTGGAGTCTACTGGCGTCTT-3' (sense), and 5'-CAGTCTTCTGAGTGGCAGTGATGG-3' (antisense). Expression of the target gene was normalized against the expression of GAPDH (ABI Prism 7700 sequence detector system, Applied Biosystems, SDS (Ver. 1.91, Foster City, CA).
Statistical analysis
Numerical data were expressed as mean 7standard error of the mean (SEM). Significant difference between two groups was determined by the Student's t-test. Significant differences among groups (4 2) were determined by one-way factorial ANOVA followed by the Newman-Keuls test. Po 0.05 was considered significant.
Results
Expression of NOX5 mRNA
Previous studies have shown that mRNA and protein levels of Nox isoforms (Nox2, and Nox4) are greater in RPT cells from SHRs than WKY rats [31, 39, 40] ; Nox1, Nox2, and Nox4 expressions are also increased in vascular smooth muscles cells of SHRs [4] . In the current report, we determined which NADPH oxidase isoform contributed to the enhanced NADPH oxidase activity in RPT cells from HT, relative to NT. In contrast to the studies in rats, we found that in human RPT cells, NOX2 and NOX4 mRNAs were similar in NT and HT. In agreement with the studies in vascular smooth muscle cells of SHRs [4] , NOX1 mRNA was greater in HT than NT ( Supplementary Fig. S1 ). The mRNA expression of NOX5, which is found in humans but not rodents, was also greater in HT (3.5 70.1 fold) than NT (1.0 70.2) (Fig. 1A) . The increased basal NOX5 mRNA in HT relative to NT was verified by real-time qPCR; NOX5 mRNA was 4.2 70.7-fold greater in HT than NT (P o0.001, vs. NT, n ¼4, t-test) (Fig. 1B) .
Protein profile of NADPH oxidase isoforms in Human RPT cells
Except for NOX3 and DUOX, the five other NOX isoforms are ubiquitously expressed in tissues and organs of humans. NOX1, NOX2, and NOX4 proteins, which are present in RPT cells from humans [8] and rats, are expressed to a greater extent in SHRs than WKY rats [4, 31, 39, 40] . We, therefore, determined whether or not NADPH oxidase isoform protein expression is also greater in RPT cells from hypertensive than normotensive humans (i.e., HT vs. NT). In agreement with the mRNA data, total cellular NOX2 and NOX4 proteins were similar in NT and HT ( Fig. 2A and B) , while total cellular NOX1 protein was slightly greater in HT (1.270.-fold) than NT (P¼ 0.016) ( Fig. 2A and B) . By contrast, total cellular NOX5 protein was markedly greater in HT (5.2 70.7-fold) than NT ( Fig. 2A and B) . Similar results were obtained using four other RPT cell lines from HT (n ¼2) and NT (n ¼2) (Fig. S2 , supplementary file). NOX3 protein was not found in human RPT cells, in agreement with a previous report [13] . We also studied the effect of the number of cell passages on NOX5 mRNA expression, NOX5 protein, and ROS production (6 vs. 20 passages). NOX5 expression and ROS production were not different after 6 or 20 passages of HT cells ( Fig. S3 supplementary file) . In addition, 3 pairs of human RPT primary cells (4-10 passages) were studied for NOX5 protein expression and activity. In these lower passaged RPT cells, NOX5 protein was also greater in HT than NT (Fig. S4A , supplementary file); ROS production was also greater in HT (349 791% of NT) than NT cells (100 73.0) (Fig. S4B , supplementary file).
Apical and basolateral membrane localization of NADPH oxidase isoform proteins NOX5 was found in the perinuclear region and plasma membrane in human endothelial cells [15] and NOX5-transfected human embryonic kidney (HEK) 293 cells [20, 21] . In RPT cells from NT, endogenous NOX5 was localized to a greater extent at the perinuclear area and to a lesser extent at the cell membrane (Fig. 3A, upper panel) . In contrast, in RPT cells from HT, NOX5 was predominantly localized at the cell membrane but was present also in the cytosol and nucleus and co-localized with ROS (Fig. 3A , lower panel, and Fig. S5 supplementary file). ROS production was abrogated by pretreatment of the HT cells with the NADPH oxidase inhibitor, diphenyleneiodonium (DPI), and superoxide dismutase (SOD) which dismutates superoxide to hydrogen peroxide (Fig. 3B) . The presence of NOX5 protein at the RPT cell membrane in HT was confirmed by biotinylation studies (Fig. S6 , supplementary file). We quantified the protein levels of NOX isoforms (NOX1, 2, 4, and 5) at the apical membrane by cell surface biotinylation, immunoprecipitation, and immunoblotting with specific anti-NOX isoform antibodies. NOX1, NOX2, and NOX4 proteins were expressed to a greater extent in apical than basolateral membranes of RPT cells from both NT and HT ( Fig. 3C and D) . Furthermore, NOX1, NOX2, NOX4, and NOX5 protein levels were greater in the apical membranes of RPT cells from HT than NT; NOX5 protein, in particular, was 2.8 70.5-fold greater in HT than NT (Fig. 3C and D, and Table S1 , supplementary file). Thus, while total cellular NOX1 and NOX5 proteins but not NOX2 and NOX4 were greater in RPT cells from HT than NT, apical membrane expressions of NOX1, NOX2, NOX4, and NOX5 were all increased in HT relative to NT.
However, of these NOX isoforms, the total cellular and apical membrane expression of NOX5 was increased to a greater extent than the other NOX isoforms in HT, relative to NT.
NADPH oxidase activity and ROS production
We used four different methods to measure NADPH oxidase activity and/or ROS production in RPT cells. First, total NADPH oxidase activity was measured in the presence of lucigenin and NADPH using whole cell membranes (Fig. 4A) , as reported previously [8, 31] . We have previously reported that basal NADPH oxidase activity was greater in RPT cells from SHRs than from WKY rats [31] . In the current study, basal total NADPH oxidase activity was also greater in RPT cells from HT (4.570.2-fold) than NT (Fig. 4A) . In contrast, the D 1 -like receptor agonist fenoldopam, using a concentration that is less than the Vmax [29] , decreased NADPH oxidase activity to a greater extent in RPT cells from NT ( À32.5 7 1.8%) than HT ( À 14.8 71.8%) (P o0.01, t-test) (Fig. 4B) . The effect of fenoldopam was specific to the D 1 -like receptor because the inhibitory effect of fenoldopam on NADPH oxidase activity was reversed by the addition of the D 1 -like receptor antagonist Sch23390 in both NT and HT (Fig. 4B) .
Calcium-dependent NADPH oxidase activity in total cell membranes was measured in the presence of 1.0 mmol/L CaCl 2 since NOX5 is a calcium-dependent enzyme [9, 14, 18, 19, 23] . NADPH oxidase activity expressed % control (no ionomycin) or RLUs is shown in Fig. S7A and B in the supplementary file. As shown in Fig. 4C , Left figure, calcium-independent NADPH oxidase activity was 2.3 70.3-fold greater in HT (230 733%) than NT cells (100 71.6%) (P ¼0.003). However, calcium-dependent NADPH oxidase activity was even greater (3.670.7-fold) in HT (362 735%) than NT (100 77.6%) (P ¼0.001) (Fig. 4C, right figure) .
NOX5 is a calcium-dependent enzyme and ionomycin, which raises the intracellular level of Ca 2 þ , stimulates NOX5 activity [9, 14, 18, 19] . Therefore, we studied the effect of ionomycin on NOX5 activity using whole cell membranes from HT cells only because NOX5 protein expression was minimally expressed in NT cells ( Figs. 1 and 2 ). Ionomycin stimulated NADPH oxidase activity only in the presence of calcium (Fig. S7A , supplementary file) [18] . Ionomycin increased membrane NADPH oxidase activity (þ127.3 76.0% vs. 100.6 7 1.8%, vehicle control) (P¼ 0.008, vs. control, ANOVA) (Fig. 4D) . The stimulatory effect of ionomycin on NADPH oxidase activity was decreased below control values by SOD, or DPI. Second, NOX5-specific oxidase activity was measured in immunoprecipitated NOX5 in the presence of CaCl 2 . In HT and NT cells (4-18 passages) NOX5 activity in NOX5 immunoprecipitates was 2791.9 7 200.7 RLU in HT vs. 432.3 7128.5 RLU in NT (P ¼0.003), Table S2 , supplementary file). Fig. 5A, left figure, shows that basal NOX5 activity (measured immediately after the injection of NADPH, in the presence of calcium) was 6.2-fold greater in HT (624725% of NT) than NT (100 74%) (P o0.001, t-test, n ¼6-14). The amount of NOX5 pulled down (Fig. S8 supplementary file) was also greater in HT (244 75%) than NT (10272%) (P ¼0.03). Fig. 5A , right figure shows the NOX5 activity monitored over a period of 30 min. Following the injection of NADPH, NOX5 activity increased with the time, peaked at 10 min and started to decline at 15 min. Fig. 5B shows that in HT cells, ionomycin increased NOX5 activity by 257 6.3% compared with control (vehicle-treatment) (P o0.01 vs. control, one-way ANOVA). The effect of ionomycin on NOX5 activity was abrogated by pre-treatment of HT cells with either DPI or SOD, both of which decreased NOX5 activity below control values, similar to those observed for total NADPH oxidase activity (Fig. 4D) .
Third, extracellular ROS production was measured by SODinhibitable reduction of cytochrome c in live RPT cells [19] [20] [21] 37, 38] . To evaluate the relationship between the localization of the NOX isoforms at the apical membranes and extracellular ROS production, we measured extracellular ROS production using the SOD-inhibitable reduction of cytochrome c. We found that extracellular ROS production was 2.6-fold greater in HT (45. [ 31-33, 36, 40] . These previous reports were corroborated by the current studies in that the D 1 -like receptor agonist fenoldopam decreased ROS production to a greater extent in NT ( À 39.1 75.8) than HT ( À 17.1 72.6) (Fig. 5C ), in agreement with its decreased ability to inhibit NADPH oxidase activity in HT (Fig. 4B) . Finally, we used a fluorescence kit to label live RPT cells and visualized ROS production by confocal microscopy. The fluorescence intensity, measured under the same microscope setting, was much stronger in RPT cells from HT than NT, indicating that basal ROS production was greater in HT than NT (Fig. 5D) , corroborating the results using the other methods to measure ROS production (Figs. 4A, C, and 5C ). The finding that NOX5 colocalized with ROS in RPT cells from HT ( Fig. 3A and Fig. S5 ) indicated that intracellular ROS abundance was related to NOX5 protein abundance.
Effect of knockdown of NOX5 expression on NADPH oxidase activity
To determine if the increased NOX5 activity in RPT cells from HT was causal of the increased ROS production, we measured NADPH oxidase activity following the silencing of NOX5, using NOX5-siRNA. Because NOX5 protein in NT cells was barely detectable (Fig. 3A, Figs. S2, S4 and S5) , only RPT cells from HT were used in the silencing experiments. To determine whether or not loss of NOX5 expression altered cellular behavior, cell number was measured following the silencing of NOX5 with NOX5-siRNA in HT cells. Silencing NOX5 decreased NOX5 protein by 5679% (Fig. 6A) but did not alter cell number (Figs. S9A and B , supplementary file). In another set of studies, NOX5 protein expression was decreased by À 40 76.2% (data not shown) and NADPH oxidase activity was decreased by À 457 3.2% (Fig. 6B ) in NOX5-siRNA treated HT RPT cells, relative to mock-siRNA-treated HT RPT cells. NOX5 activity was also measured with or without ionomycin following the silencing of NOX5 gene. Ionomycin increased NOX5 activity to a greater extent in mock-silenced (mock-siRNA) HT cells (þ31.3 72.8%) than in NOX5-silenced (NOX5-siRNA) HT cells (þ14.6 73.2%) (Po 0.02, ANOVA) (n ¼6) (Fig. 6C) ; SOD or DPI decreased NADPH oxidase activity in both mock-siRNA and NOX5-siRNA-treated RPT cells, to levels below control values, similar to HT cells not treated with NOX5-siRNA (Fig. 5B) . . Measurement of calcium-independent and calcium-dependent NADPH oxidase activity in RPT cells. Whole cell membranes were prepared as described under "Section 2". NADPH oxidase activity was measured in the absence or presence of CaCl 2 (1.0 mmol/L). The calcium-independent (left figure) and -dependent (right figure) NADPH oxidase activities were expressed as RLU/50 μg protein (Fig. S7B ) and expressed as % of NT (Fig. 4C) . Values are mean 7 SEM (n¼ 8-12/group), (18) . The cell pellets were collected and whole cell membranes were prepared as in Fig. 4A . NADPH oxidase activity was measured using a microplate luminometer as described under "Section 2". NADPH oxidase activity was expressed as % of control and shown as mean 7 SEM (n¼ 4/group). 
Discussion
The role of NOX isoforms in physiological and pathological states is well documented. However, studies of NOX5 are relatively rare because this gene is not found in rodents [12, 13] . By contrast, the NOX5 gene is present in humans and its protein is expressed in fetal [13] and non-fetal organs and tissues, including the lung, testis, spleen [14] , and vascular endothelial, smooth muscle [3, 7, 9, 10, [15] [16] [17] 41] , and gastrointestinal [42] cells. We now show for the first time that NOX5 mRNA and protein are expressed in human RPT cells.
NADPH oxidase enzymes are the major sources of ROS production in renal and cardiovascular tissues [2, [4] [5] [6] [7] [8] [9] . The increased generation of ROS contributes to human [10, 11] and animal hypertension [2, 4, 5, 10, [29] [30] [31] [32] 43] . NADPH oxidase activity and superoxide formation are increased in endothelial [2, 10, 41, 43] , neural [5, 43] , renal [2, [29] [30] [31] [32] 43, 44] , and vascular smooth muscle cells [4, 28, 41, 43] in genetic and acquired hypertension. Of the Nox isoforms that are present in rodents (Nox1, Nox2, and Nox4) [2, [7] [8] [9] [29] [30] [31] [32] 39] , Nox4 has been claimed to be the major NADPH oxidase in renal [6, 43] , vascular smooth muscle [4, 7, 41, 43] , and endothelial cells [41, 43] , and its expression is markedly increased in hypertensive rodents [2, 31, 35, 43] . It has also been reported that injection of siRNA against-NOX2 or NOX4 into the hypothalamic paraventricular nucleus attenuates the development of aldosterone/salt-induced hypertension [5] . Therefore, Nox4 may play vital role in the pathogenesis of animal hypertension. By contrast, human microvascular endothelial cells possess functionally active NOX5 which generates ROS and is regulated by angiotensin II and endothelin 1 [14] [15] [16] 41] . In patients with coronary artery disease, NOX5 protein and mRNA levels and NADPH oxidase-dependent production of ROS in coronary arterial membranes are increased [9] . We now report for the first time that NADPH oxidase activity and mRNA and total cellular protein expressions of NOX5 and NOX1, but not NOX2 and NOX4 are increased in RPT cells from HT relative to NT. We also report that the apical membrane expressions of NOX1, NOX2, NOX4, and NOX5 are increased in RPT cells from HT relative to NT. However, the increase in NOX5 expression in HT is greater than the other NOX isoforms. Moreover, the increase in NOX5 expression and activity in HT is associated with increased production of ROS. Therefore, we speculate that increased NOX5 expression may be important in the pathogenesis of human essential hypertension.
The increase in NOX proteins, especially NOX5 at the apical and plasma membranes in RPT cells from HT, is associated with increased extracellular ROS production. This may be related to polybasic domains within the N-terminus of NOX5, that can bind phosphatidylinositol 4,5-bisphosphate at the plasma membrane, and promote the trafficking and cell surface expression of NOX5 [20, 21] . NOX5 in the endoplasmic reticulum and nucleus may also contribute to intracellular ROS production [20, 21, 23] . The colocalization of NOX5 with ROS in RPT cells from HT could be taken to indicate that the increased intracellular ROS in HT is related to NOX5 protein abundance.
NOX5 protein is expressed predominantly in the plasma membrane and to a lesser extent in the cytosol and nucleus. NOX1-5 proteins have been reported to be expressed in many subcellular areas, including the nucleus in human endocardial and vascular endothelial, vascular smooth muscle, esophageal adenocarcinoma, prostate cancer, and leukemia cells [18, 41, 42, 44, 45] . In agreement with these reports, confocal imaging shows that NOX5 protein and ROS colocalize in the plasma membrane and nucleus of RPT cells from HT. Therefore, nuclear NOX5-dependent ROS production may also contribute to total cellular oxidative stress. Whether or not nuclear NOX5 is involved in redox responsive gene expression remains to be determined [44] .
Ionomycin, an ionophore that increases intracellular Ca 2 þ and NADPH oxidase activity [14, 18, 19] , also stimulates NOX5 activity in HT cells. The stimulatory effect of ionomycin on ROS production is abrogated by DPI, an NADPH oxidase inhibitor, and SOD which catalyzes the dismutation of superoxide to H 2 O 2 . These data support the notion that activation of NOX5 is responsible for the increase in ROS production, specifically superoxide. There are at least five splice variants of NOX5 (α, β, δ, γ, and ε) [15, 23] . Ionomycin stimulates NOX5α and β but not the other NOX5 isoforms to produce superoxide [23] . It remains to be determined whether these NOX5 isoforms are responsible for the increased ROS production in RPT cells from HT or NOX5 polymorphisms, if they exist, are associated with the hypertensive phenotype. Nevertheless, increased NOX5 expression and activity are likely to be important in the increased ROS production in RPT cells from HT because silencing of NOX5 with siRNA decreases basal NADPH oxidase activity in RPT cells from HT. We and others have previously reported that ROS production is negatively regulated by D 1 -like receptors in RPT cells from humans [8] and RPT and vascular smooth muscle cells from rats [28] [29] [30] [31] [32] . The inhibitory effect of fenoldopam, a D 1 -like receptor agonist, on NADPH oxidase activity is probably exerted at the D 1 -like receptor because a D 1 -like receptor antagonist, Sch23390, blocks the fenoldopam effect. The decreased ability of fenoldopam to inhibit NADPH oxidase activity in HT relative to NT is in agreement with our previous report that fenoldopam inhibits NADPH oxidase activity to a lesser extent in RPT cells from SHRs than those from normotensive WKY rats [31] . A defective D 1 -like receptor may have caused the impaired ability of fenoldopam to inhibit NADPH oxidase activity in the RPT cells from HT. We and others have reported a decreased ability of D 1 -like receptors to inhibit RPT sodium reabsorption [27] , and stimulate cAMP production and inhibit sodium transport in RPT cells from hypertensive humans [33] , three animal models of hypertension [11, 24, 32] , and obese hypertensive rats [46] . The impairment in renal proximal tubular D 1 -like receptor function in hypertension is caused by constitutive phosphorylation of D 1 R, as a consequence of increased activity of type 2 and type 4 G protein-coupled receptor kinases [24, 33, 46, 47] .
In conclusion, we report for the first time that NOX5 is the predominant NOX isoform expressed in human RPT cells and its expression and activity in RPT cells are increased in humans with essential hypertension. Although the latter conclusion is limited by the small number of subjects (three normotensive and three hypertensive subjects), NOX5 expression in RPT cells was always greater in HT than in NT. Thus, it is likely that increased NOX5 expression and activity may be responsible for the oxidative stress that contributes to the pathogenesis of human essential hypertension.
